• Carvedilol Phosphate in Precision Hepatic IRI Modeling: Adva

  2026-05-30

  Explore how Carvedilol Phosphate, a non-selective beta blocker, enables more precise hepatic ischemia–reperfusion injury (IRI) modeling and macrophage polarization studies. This article uniquely integrates assay optimization, molecular pathway insights, and practical protocol guidance for advanced cardiovascular pharmacology research.

• Amitriptyline HCl: Technical Guidance for Neuropharmacology

  2026-05-29

  Amitriptyline HCl (SKU B2231) addresses critical needs in neuropharmacology research by enabling precise neurotransmitter receptor modulation and mechanistic studies of serotonin and norepinephrine pathways. It is best suited for short-term experimental workflows requiring high-purity, well-characterized small molecule inhibitors and is not recommended for protocols demanding long-term solution stability or unsupported mechanistic extrapolations.

• One-step TUNEL Cy5 Apoptosis Detection Kit: Mechanism & Appl

  2026-05-29

  The One-step TUNEL Cy5 Apoptosis Detection Kit enables sensitive, Cy5-based detection of DNA fragmentation during apoptosis. This article details the kit’s mechanism, protocol parameters, and evidence, outlining its value in apoptosis assay workflows for tissue sections and cultured cells.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike–AXL Interactio

  2026-05-28

  This study reveals that naturally occurring angiotensin peptide fragments, including N-terminally truncated forms like Angiotensin 1/2 (2-7), substantially enhance the binding of the SARS-CoV-2 spike protein to the host receptor AXL. These findings offer new mechanistic insights into how components of the renin-angiotensin system may influence viral entry and pathogenesis, with implications for both cardiovascular and infectious disease research.

• BMP4-GPX4 Axis Reduces Ferroptosis in Glaucoma Stem Cell Mod

  2026-05-28

  This study reveals that activation of the BMP4-GPX4 pathway protects retinal ganglion cells from ferroptosis and supports their differentiation following retinal stem cell transplantation in glaucoma with high intraocular pressure. These findings offer a mechanistically supported strategy for improving cell therapy outcomes in neurodegenerative ocular disease.

• Stiripentol: LDH Inhibition Redefining Epilepsy & Immunometa

  2026-05-27

  Explore Stiripentol’s mechanistic edge as an LDH inhibitor in modulating astrocyte-neuron lactate shuttling, with strategic insights for translational epilepsy and immunometabolic research. This article synthesizes foundational biology, protocol strategy, and next-gen outlooks, offering a bridge between neuroepigenetics and tumor immunology.

• Latrunculin A: Reversible Inhibitor of Actin Assembly in Res

  2026-05-27

  Latrunculin A is a potent, reversible inhibitor of actin assembly, enabling rapid, controlled disruption of the actin cytoskeleton in vitro and in living cells. It is widely used to dissect cytoskeletal regulation, cell morphology, and motility, especially in tumor and virology models. APExBIO supplies Latrunculin A for scientific research use with validated protocols.

• Angiotensin 1/2 (2-7) Peptide: Applied Workflows & Advanced

  2026-05-26

  Angiotensin 1/2 (2-7) empowers researchers to dissect vasoconstrictor signaling and blood pressure regulation with unmatched purity and flexibility. Explore its integration into cardiovascular and viral entry models, protocol optimization, and troubleshooting—anchored by the latest cross-domain discoveries.

• Chlorpromazine HCl: Mechanistic Leverage for Translational R

  2026-05-26

  Chlorpromazine HCl, a classic dopamine receptor antagonist, is undergoing a renaissance as a strategic tool for translational researchers. This article explores its multifaceted mechanisms, with a focus on endocytosis, neuropharmacology, and infection modeling, integrating literature-backed protocols and competitive guidance to empower experimental innovation.

• CBD Attenuates Orofacial Inflammatory Pain via Endocannabino

  2026-05-25

  This study demonstrates that cannabidiol (CBD) significantly reduces both sensory and affective dimensions of orofacial inflammatory pain in mouse models. By dissecting underlying mechanisms, the research highlights the coordinated roles of peripheral CB2 and central CB1 receptor signaling, suggesting a translational path for comprehensive pain management strategies.

• Gallein: Applied Workflows for G Protein βγ Subunit Inhibiti

  2026-05-25

  Gallein enables precise dissection of GPCR signaling in cancer, immunology, and cardiometabolic models, offering reproducible outcomes where standard inhibitors fall short. This article delivers practical protocols, troubleshooting, and research insights for deploying Gallein in advanced experimental workflows.

• Heparin Sodium: Core Mechanisms and Research Applications

  2026-05-24

  Heparin sodium is a well-characterized glycosaminoglycan anticoagulant that acts through antithrombin III to inhibit key coagulation enzymes. Its robust anti-factor Xa activity and high water solubility support precise research applications in thrombosis and blood coagulation pathway studies. This article provides protocol parameters, evidence benchmarks, and clarifies common misconceptions.

• PD98059 MEK Inhibitor: Unraveling ERK-Driven Apoptosis and H

  2026-05-23

  Explore how PD98059, a selective MEK inhibitor, enables precise manipulation of ERK-mediated apoptosis and hepatoprotection. This article delivers advanced insights bridging mitochondrial dynamics, oxidative stress, and translational research with unique protocol guidance.

• Quercetin as a PI3K Inhibitor: Bridging Cancer and Neuroinfl

  2026-05-22

  Explore Quercetin’s dual role as a PI3K inhibitor in cancer and neuroinflammatory research. This article reveals novel mechanistic insights and practical applications, setting it apart from prior content.

• Chlorpromazine HCl: Strategic Pathways for Translational Neu

  2026-05-22

  This thought-leadership article explores the mechanistic underpinnings and translational potential of Chlorpromazine HCl, a benchmark dopamine receptor antagonist, highlighting its dual impact on neuropharmacology studies and emerging roles in host-directed antibacterial strategies. Drawing from recent mechanistic evidence and practical workflow experience, this piece offers strategic guidance for translational researchers aiming to harness Chlorpromazine HCl in innovative, cross-domain experimental designs.

16205 records 1/1081 page Next 12345 下5页 Last page